123 related articles for article (PubMed ID: 4153181)
1. [Clinical experiences with a new beta-sympatholytic agent Kö 1366 (bunitrolol)].
Wallnöfer H; Täuber K
Wien Med Wochenschr; 1974 Sep; 124(38):550-7. PubMed ID: 4153181
[No Abstract] [Full Text] [Related]
2. [Studies on the influence of a beta-receptor blocking agent on plasma renin activity in man].
Distler A; Abdelhamid S; Philippi A; Rahn KH
Verh Dtsch Ges Inn Med; 1971; 77():937-9. PubMed ID: 4405363
[No Abstract] [Full Text] [Related]
3. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
4. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
Marmo E; Caputi AP; Saini RK
Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
[No Abstract] [Full Text] [Related]
5. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
Piva M; Ongari R; Dotti F
Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
[No Abstract] [Full Text] [Related]
6. [Experiences with the new beta sympatholytic agent Dalzic (ICI 50 172)].
Weber H
Med Welt; 1973 May; 24(18):749-51. PubMed ID: 4145085
[No Abstract] [Full Text] [Related]
7. Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug.
Bauer GE; Michell G
Med J Aust; 1970 Jan; 1(4):170-3. PubMed ID: 4190852
[No Abstract] [Full Text] [Related]
8. [On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
Mihail A; Popescu P; Ioan A; Bruckner I; Paraschiv A; Petrescu X; Popa N
Med Interna (Bucur); 1973 Jan; 25(1):87-93. PubMed ID: 4144020
[No Abstract] [Full Text] [Related]
9. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
Gasparotto G; Pagnan A
Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
[No Abstract] [Full Text] [Related]
10. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
Gilfrich HJ; Rahn KH; Nicolescu RF
Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
[No Abstract] [Full Text] [Related]
11. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.
Sood NK; Havard CW
Thorax; 1973 May; 28(3):331-4. PubMed ID: 4146782
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic use of beta-receptor blocking agents].
Wallnöfer H; Bereitter E
Wien Klin Wochenschr; 1968 Apr; 80(15):288-92. PubMed ID: 5688615
[No Abstract] [Full Text] [Related]
13. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Prahl P; Prahl M
Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
[No Abstract] [Full Text] [Related]
14. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
Musial W; Tracz W; Krzemińska-Pakula M
Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
[No Abstract] [Full Text] [Related]
15. [A new beta-receptor blockader as anti-arrhythmic agent].
Dahlberg A
Lakartidningen; 1972 Mar; 69(12):1334-5. PubMed ID: 4402107
[No Abstract] [Full Text] [Related]
16. [Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases].
Müller H; Barthels F; Kluthe R
Med Klin; 1973 May; 68(19):634-41. PubMed ID: 4125216
[No Abstract] [Full Text] [Related]
17. [Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
Musial W; Krzemińska-Pakula M; Tracz W
Pol Tyg Lek; 1971 Aug; 26(34):1316-8. PubMed ID: 4398697
[No Abstract] [Full Text] [Related]
18. [Beta-adrenergic blockaders in cardiology].
Muniz M
Arq Bras Cardiol; 1979 Oct; 33(4):283-92. PubMed ID: 44836
[No Abstract] [Full Text] [Related]
19. [Clinical experiences with -receptor blockader Propranolol in the treatment of angina pectoris and tachycrdiac arrhythmias].
Eisenreich R
Z Arztl Fortbild (Jena); 1970 Jun; 64(11):529-34. PubMed ID: 4106268
[No Abstract] [Full Text] [Related]
20. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
